Detalhe da pesquisa
1.
The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study.
Cancer
; 2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38376917
2.
A Review of Approaches to Potentiate the Activity of Temozolomide against Glioblastoma to Overcome Resistance.
Int J Mol Sci
; 25(6)2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38542190
3.
A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 inhibitor, in patients with relapsed/refractory acute myeloid leukemia.
Haematologica
; 108(3): 705-716, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36226495
4.
Phase 1 dose-finding study of metformin in combination with concurrent cisplatin and radiotherapy in patients with locally advanced head and neck squamous cell cancer.
Cancer
; 126(2): 354-362, 2020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31626727
5.
Proton Treatment Suppresses Exosome Production in Head and Neck Squamous Cell Carcinoma.
Cancers (Basel)
; 16(5)2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38473367
6.
A Phase 0/I Pharmacokinetic and Pharmacodynamics and Safety and Tolerability Study of Letrozole in Combination with Standard Therapy in Recurrent High-Grade Gliomas.
Clin Cancer Res
; 30(10): 2068-2077, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38530160
7.
The human DEK oncogene regulates DNA damage response signaling and repair.
Nucleic Acids Res
; 39(17): 7465-76, 2011 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21653549
8.
Small extravesicular microRNA in head and neck squamous cell carcinoma and its potential as a liquid biopsy for early detection.
Head Neck
; 45(1): 212-224, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36271833
9.
Durvalumab plus Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: An Open-label, Nonrandomized, Phase II Clinical Trial.
Clin Cancer Res
; 29(10): 1906-1915, 2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36802410
10.
Single cell transcriptomic analysis of HPV16-infected epithelium identifies a keratinocyte subpopulation implicated in cancer.
Nat Commun
; 14(1): 1975, 2023 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37031202
11.
Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium.
Lancet Reg Health Am
; 19: 100445, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36818595
12.
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19.
JAMA Oncol
; 9(10): 1390-1400, 2023 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37589970
13.
Improving Radiotherapy Response in the Treatment of Head and Neck Cancer.
Crit Rev Oncog
; 27(2): 73-84, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36734873
14.
Current Therapy for Metastatic Head and Neck Cancer: Evidence, Opportunities, and Challenges.
Am Soc Clin Oncol Educ Book
; 42: 1-14, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35486888
15.
How the Potassium Channel Response of T Lymphocytes to the Tumor Microenvironment Shapes Antitumor Immunity.
Cancers (Basel)
; 14(15)2022 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35892822
16.
Potentiation of temozolomide activity against glioblastoma cells by aromatase inhibitor letrozole.
Cancer Chemother Pharmacol
; 90(4): 345-356, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36050497
17.
Association of Neoadjuvant Pembrolizumab for Oral Cavity Squamous Cell Carcinoma With Adverse Events After Surgery in Treatment-Naive Patients.
JAMA Otolaryngol Head Neck Surg
; 148(10): 935-939, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36006622
18.
Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition.
J Immunother Cancer
; 10(11)2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36328378
19.
Phase II Trial of CDX-3379 and Cetuximab in Recurrent/Metastatic, HPV-Negative, Cetuximab-Resistant Head and Neck Cancer.
Cancers (Basel)
; 14(10)2022 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35625959
20.
Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma.
Clin Cancer Res
; 28(7): 1345-1352, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35338369